In yesterday’s Wall Street session, Clever Leaves Holdings Inc. (NASDAQ:CLVR) shares traded at $0.44, up 3.21% from the previous session.
2 analysts cover Clever Leaves Holdings Inc. (NASDAQ:CLVR), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $3.75 and a low of $0.80, we find $2.28. Given the previous closing price of $0.43, this indicates a potential upside of 430.23 percent. CLVR stock price is now 5.33% away from the 50-day moving average and -48.01% away from the 200-day moving average. The market capitalization of the company currently stands at $18.80M.
The stock has received a hold rating from 1 analysts and a buy rating from 1. Brokers who have rated the stock have averaged $2.28 as their price target over the next twelve months.
With the price target of $13, Canaccord Genuity recently initiated with Buy rating for Clever Leaves Holdings Inc. (NASDAQ: CLVR).
In other news, Fajardo Andres, Chief Executive Officer sold 57,669 shares of the company’s stock on Jan 17. The stock was sold for $23,102 at an average price of $0.40. Upon completion of the transaction, the Chief Executive Officer now directly owns 525,934 shares in the company, valued at $0.23 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 17, Chief Regulatory Officer Wilches Julian sold 4,557 shares of the business’s stock. A total of $1,826 was realized by selling the stock at an average price of $0.40. This leaves the insider owning 48,018 shares of the company worth $21127.92. Insiders disposed of 18,928 shares of company stock worth roughly $8328.32 over the past 1 year. A total of 3.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CLVR stock. A new stake in Clever Leaves Holdings Inc. shares was purchased by VIRTU FINANCIAL LLC during the first quarter worth $12,000. CHECCHI CAPITAL ADVISERS, LLC invested $10,000 in shares of CLVR during the first quarter. In the first quarter, EXODUSPOINT CAPITAL MANAGEMENT, LP acquired a new stake in Clever Leaves Holdings Inc. valued at approximately $6,000. SKAANA MANAGEMENT L.P. acquired a new stake in CLVR for approximately $5,000. LAKE POINT WEALTH MANAGEMENT purchased a new stake in CLVR valued at around $1,000 in the second quarter. In total, there are 48 active investors with 18.10% ownership of the company’s stock.
On Monday morning Clever Leaves Holdings Inc. (NASDAQ: CLVR) stock kicked off with the opening price of $0.4400. During the past 12 months, Clever Leaves Holdings Inc. has had a low of $0.29 and a high of $3.98. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 4.90, and a quick ratio of 2.90. The fifty day moving average price for CLVR is $0.4209 and a two-hundred day moving average price translates $0.8528 for the stock.
The latest earnings results from Clever Leaves Holdings Inc. (NASDAQ: CLVR) was released for Jun, 2022. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.03, beating analysts’ expectations of -$0.23 by 0.2. This compares to $0.04 EPS in the same period last year. The company reported revenue of $3.31 million for the quarter, compared to $4.03 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -18.01 percent. For the current quarter, analysts expect CLVR to generate $5.5M in revenue.
Clever Leaves Holdings Inc.(CLVR) Company Profile
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.